Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Epigenetic Regulation01:37

Epigenetic Regulation

3.4K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Epigenetic Regulation01:46

Epigenetic Regulation

32.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.5K
Lineage Commitment01:21

Lineage Commitment

3.7K
Commitment is the  process whereby stem cells:
3.7K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

2.6K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Niche-targeted therapy via YAP/TAZ activation enhances hematopoietic regeneration.

Blood·2026
Same author

Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute Leukemias.

Cancer discovery·2026
Same author

Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Blood·2026
Same author

Non-necroptotic MLKL function damages mitochondria and promotes hematopoietic stem cell aging.

Nature communications·2026
Same author

cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis.

Nature communications·2026
Same author

In vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis.

Nature communications·2026

Related Experiment Video

Updated: Nov 23, 2025

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
10:26

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

8.7K

Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies.

Satoshi Kaito1, Atsushi Iwama1

  • 1Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

International Journal of Molecular Sciences
|December 30, 2020
PubMed
Summary

Polycomb repressive complexes (PRCs) regulate cell function and are often mutated in blood cancers. Targeting these PRC mutations shows promise for improving treatment outcomes in hematologic malignancies.

Keywords:
acute leukemiahematologic malignanciesmyelodysplastic syndromesmyeloproliferative diseasepolycomb repressive complexessynthetic lethality

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.2K
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.4K

Related Experiment Videos

Last Updated: Nov 23, 2025

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
10:26

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

8.7K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.2K
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.4K

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Cancer Genomics

Background:

  • Polycomb repressive complexes (PRCs) are key epigenetic regulators controlling gene expression through histone modifications.
  • PRCs are essential for maintaining hematopoietic stem cell function by repressing genes involved in proliferation and differentiation.
  • Mutations in PRC genes (e.g., EZH2, EED, SUZ12, BCOR, BCORL1) are prevalent in hematologic malignancies.

Purpose of the Study:

  • To review the role of PRC mutations in hematologic malignancies.
  • To discuss the therapeutic potential of targeting PRC complexes and their mutations.
  • To highlight the implications of PRC dysregulation for cancer treatment.

Main Methods:

  • Review of recent scientific literature on PRC complexes and hematologic malignancies.
  • Analysis of next-generation sequencing data identifying PRC gene mutations.
  • Evaluation of preclinical and clinical studies on PRC-targeted therapies.

Main Results:

  • Most PRC mutations in hematologic malignancies impair PRC function, correlating with poor prognosis and chemoresistance, except for activating EZH2 mutations in lymphoma.
  • PRC2 inhibitors demonstrate therapeutic efficacy in preclinical models and some clinical settings.
  • EZH2 loss-of-function mutations present opportunities for synthetic lethality-based therapeutic strategies.

Conclusions:

  • Epigenetic dysregulation by PRCs is a significant factor in hematologic malignancies.
  • Targeting PRC components, particularly mutated forms, offers a promising therapeutic avenue.
  • Further research into PRC-mediated epigenetic alterations can lead to improved treatment strategies for blood cancers.